ALLMedicine Cardiac Markers Center

May 31st, 2020 - This study tested if the protective anti-remodeling effect of GLP-1 agonist Exendin-4 after an acute myocardial infarction (MI) in rats involves inhibition of the Wnt1/β-catenin signaling pathway. Rats were divided into sham, sham + Exendin-4 (10 ...

May 20th, 2020 - Severe acute respiratory syndrome coronavirus 2 infection in children mainly shows a milder course. In complicated cases, it is unknown whether inflammation is predictive of disease severity, as in adults. Moreover, cardiac involvement is anecdota...

Apr 19th, 2020 - Background Laboratory overutilization is associated with diagnostic error and potential patient risk. We applied a demand management strategy in collaboration with the local Department of Cardiology to reduce the cardiac markers high-sensitive tro...

Mar 2nd, 2020 - Acute myocardial infarction is the leading cause of mortality and morbidity in a patient with polycythemia vera (PV). However, the benefit of various percutaneous coronary intervention (PCI) technique on the patient with PV is relatively unexplore...

Feb 24th, 2020 - Drug-drug interactions are undesirable, as they reduce drug bioavailability. Drug-reagent interactions in biochemical tests may directly affect the accuracy of test results. The aim of the present study was to investigate the impact of drug-reagen...

Jan 18th, 2018 - This document is an essential companion to the third iteration of the National Academy of Clinical Biochemistry [NACB,8 now the American Association for Clinical Chemistry (AACC) Academy] Laboratory Medicine Practice Guidelines (LMPG) on cardiac m...

May 31st, 2020 - This study tested if the protective anti-remodeling effect of GLP-1 agonist Exendin-4 after an acute myocardial infarction (MI) in rats involves inhibition of the Wnt1/β-catenin signaling pathway. Rats were divided into sham, sham + Exendin-4 (10 ...

May 20th, 2020 - Severe acute respiratory syndrome coronavirus 2 infection in children mainly shows a milder course. In complicated cases, it is unknown whether inflammation is predictive of disease severity, as in adults. Moreover, cardiac involvement is anecdota...

Apr 19th, 2020 - Background Laboratory overutilization is associated with diagnostic error and potential patient risk. We applied a demand management strategy in collaboration with the local Department of Cardiology to reduce the cardiac markers high-sensitive tro...

Mar 2nd, 2020 - Acute myocardial infarction is the leading cause of mortality and morbidity in a patient with polycythemia vera (PV). However, the benefit of various percutaneous coronary intervention (PCI) technique on the patient with PV is relatively unexplore...

Feb 24th, 2020 - Drug-drug interactions are undesirable, as they reduce drug bioavailability. Drug-reagent interactions in biochemical tests may directly affect the accuracy of test results. The aim of the present study was to investigate the impact of drug-reagen...

Jun 25th, 2015 - Slide 1. (Enlarge Slide) Ronald H. Wharton, MD: Good afternoon. This is Dr. Ronald Wharton from Montefiore Medical Center in the Bronx, New York. I thought I would share with you an interesting, and what I thought was an instructive, case. I call ...

Jul 24th, 2008 - Action Points Explain to interested patients that the study supported the clinical impressions of emergency department physicians for MI. Note that the study was observational and may have been subject to bias as only patients who were worked up w...

Nov 30th, 2005 - Introduction: Cardiac Markers: Something Old, Something New This update is based on a lecture given by Elliott Antman, MD,[1] cardiologist and clinical researcher at Harvard Medical School and Brigham and Women's Hospital in Boston, Massachusetts,...

Dec 2nd, 2004 - Dec. 3, 2004 — The U.S. Food and Drug Administration (FDA) and Tosoh Bioscience, Inc., warned healthcare professionals via letter of a class 1 recall of AIA-600 II Enzyme Immunoassay analyzer software, version 3.02 and lower, for use with the ST A...

Oct 2nd, 2001 - Wed, 03 Oct 2001 21:00:00 Boston, MA - New cardiac biomarkers used to diagnose or predict cardiovascular risk in acute coronary syndromes (ACS) may also be able to detect risk in patients who do not have increased levels of more traditionally test...